The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Nicole Wright, from North Ayrshire, Scotland, wanted to lose weight before an upcoming vacation to Turkey. In August she ...

"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

Gubra’s once-weekly obesity candidate was tied to 3% weight loss during a six-week phase 1 trial, with a single injection ...

Metabolism-targeting injections could pave the way for a new treatments, detection and prevention of bowel cancer ...

In the world of weight-loss treatments, two injections have been trending like never before – semaglutide, sold as Wegovy or Ozempic and tirzepatide, branded as Mounjaro. These injections are designed ...

The key drugs in the weight-loss injection market are Ozempic, Wegovy and Mounjaro. Understandably, there has been a flurry of interest into the details about these drugs – the differences ...

The key drugs in the weight-loss injection market are Ozempic, Wegovy and Mounjaro. Understandably, there has been a flurry of interest into the details about these drugs – the differences between ...